The biosimilar market is evolving rapidly, with an ever-changing regulatory landscape and new market entrants in both emerging and developed markets. Since the first biosimilar regulatory framework was introduced by EMA in 2003 (followed by U.S. in 2009, WHO in 2010 and India in 2016) the industry has matured.

 

Click here to read our biosimilars fact sheet

Contact Us
Call Our Team 

Phone: +1 919 876 9300
Fax: +1 919 876 9360
Toll-Free: +1 866 462 7373

Corporate Headquarters

3201 Beechleaf Court
Suite 600
Raleigh, NC 27604-1547